ValueVector has the capabilities and the competencies to assist companies operating in the global health care market in :
|
Education and training courses in: international, national and local health systems policies; market access, pricing and reimbursement, case studies of pharmaceutical and biotech products; pharmacoeconomic strategies.
Analyzing their business environment – with particular focus on the intricacies of the international pricing and reimbursement systems
Assessing international pricing and reimbursement issues and opportunities for their products
|
|
Developing realistic forecasts, including the pricing and reimbursement dimensions in the business outlook
Creating high quality global and national Value Dossiers to use in discussions with payers and for pricing and reimbursement applications
Designing and implementing product development and regulatory strategies aimed at maximizing pricing and reimbursement opportunities
Successfully integrating pricing and reimbursement in the overall product marketingstrategy, striking the optimal balance between all the elements of the marketing mix
Implementing their global pricing and reimbursement strategies
Addressing potential pricing and commercial issues arising in the context of licensing and other partnering deals
|
Having started operations in September 2003, ValueVector has already undertaken projects with numerous European and global clients, in the following therapeutic areas: |
Bacterial Infections
Dermatology
Fungal Infections (Systemic)
Oncology
Osteoporosis
Rare Diseases (Orphan Drugs)
Vaccines |
|